Back | Next |
home / stock / rdhl / rdhl message board
Subject | By | Source | When |
---|---|---|---|
$RDHL Do we have a winner?Turn around time? | Big Wheel | investorshub | 04/26/2023 11:35:14 PM |
$RDHL MomentumIts trading | midastouch017 | investorshub | 04/26/2023 7:49:20 PM |
$RDHL MomentumIts now | carusso | investorshub | 04/26/2023 6:28:40 PM |
$RDHL Good read | carusso | investorshub | 04/26/2023 4:41:31 PM |
RedHill Biopharma Granted US Patent for Cancer Treatment Combination | midastouch017 | investorshub | 04/26/2023 9:54:00 AM |
Good news recently, we should start to see this one move | midastouch017 | investorshub | 04/26/2023 9:19:52 AM |
$RDHL The trading last trade up | seve333 | investorshub | 04/26/2023 1:20:06 AM |
Price now | midastouch017 | investorshub | 04/25/2023 8:18:15 PM |
Price gaining | midastouch017 | investorshub | 04/25/2023 8:12:05 PM |
Price gaining | midastouch017 | investorshub | 04/25/2023 1:16:01 AM |
The trading last up | seve333 | investorshub | 04/25/2023 12:29:52 AM |
Price now last trade up | midastouch017 | investorshub | 04/24/2023 10:05:13 PM |
Good read | seve333 | investorshub | 04/24/2023 5:36:54 PM |
$RDHL short squeeze signal | Scrapiron | investorshub | 04/24/2023 4:27:03 PM |
$RDHL Price gaining | midastouch017 | investorshub | 04/24/2023 12:58:39 PM |
is it bear time? Or do we go bull? | carusso | investorshub | 04/24/2023 10:57:07 AM |
$RDHL The gaining | Big Wheel | investorshub | 04/24/2023 6:14:35 AM |
$RDHL Price gaining | midastouch017 | investorshub | 04/24/2023 5:29:00 AM |
$RDHL When is this gonna take off? | midastouch017 | investorshub | 04/24/2023 3:58:56 AM |
The gaining up | midastouch017 | investorshub | 04/24/2023 3:25:43 AM |
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study PR Newswire First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat) 1 for early COVID-19 outpatient treatment, funded through non-...
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire RedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base ...
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , April 2, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialt...